Sodium Nitrite Injection

MARCH 01, 2004

Hope Pharmaceuticals (Scottsdale, Ariz) recently announced the release of Sodium Nitrite Injection USP 3% in singledose vials. This product is indicated for the treatment of cyanide poisoning. It is a primary component of the Cyanide Antidote Kit, which is used by hospitals and public safety authorities for emergency preparedness. Cyanide inhalation can cause severe toxic effects and death within minutes to hours. Prompt treatment is critical for patient survival. The new vials facilitate rapid administration during an emergency. For more information, visit www.hopepharm.com.



SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.